Healthcare provider profile · identity verified

Robert A W Latimer, M.D.

Family Practice · MANASSAS, VA · NPI 1053311555

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	700	189
Rosuvastatin Calcium	Rosuvastatin Calcium	558	154
Amlodipine Besylate	Amlodipine Besylate	540	141
Levothyroxine Sodium	Levothyroxine Sodium	423	113
Losartan Potassium	Losartan Potassium	400	101
Metoprolol Succinate	Metoprolol Succinate	379	102
Metformin Hcl	Metformin Hcl	378	100
Simvastatin	Simvastatin	352	94
Lisinopril	Lisinopril	351	89
Pantoprazole Sodium	Pantoprazole Sodium	273	83
Hydrochlorothiazide	Hydrochlorothiazide	252	68
Gabapentin	Gabapentin	239	72
Glimepiride	Glimepiride	215	59
Tamsulosin Hcl	Tamsulosin Hcl	206	60
Omeprazole	Omeprazole	204	48
Sertraline Hcl	Sertraline Hcl	178	45
Atenolol	Atenolol	170	43
Allopurinol	Allopurinol	166	44
Eliquis	Apixaban	160	41
Clopidogrel	Clopidogrel Bisulfate	144	38
Ezetimibe	Ezetimibe	141	39
Furosemide	Furosemide	133	56
Alprazolam	Alprazolam	130	24
Montelukast Sodium	Montelukast Sodium	130	31
Jardiance	Empagliflozin	123	32
Pioglitazone Hcl	Pioglitazone Hcl	114	30
Trazodone Hcl	Trazodone Hcl	105	24
Citalopram Hbr	Citalopram Hydrobromide	103	26
Prednisone	Prednisone	101	61
Carvedilol	Carvedilol	99	30
Metoprolol Tartrate	Metoprolol Tartrate	93	26
Zolpidem Tartrate	Zolpidem Tartrate	92	13
Albuterol Sulfate Hfa	Albuterol Sulfate	90	41
Tramadol Hcl	Tramadol Hcl	89	23
Fluticasone Propionate	Fluticasone Propionate	79	25
Bupropion Xl	Bupropion Hcl	76	22
Glipizide	Glipizide	75	22
Mounjaro	Tirzepatide	71	11
Trulicity	Dulaglutide	67	16
Duloxetine Hcl	Duloxetine Hcl	66	15
Synthroid	Levothyroxine Sodium	64	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	63	54
Finasteride	Finasteride	63	19
Valsartan	Valsartan	63	20
Pravastatin Sodium	Pravastatin Sodium	62	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	13
Donepezil Hcl	Donepezil Hcl	58	19
Famotidine	Famotidine	58	19
Doxycycline Hyclate	Doxycycline Hyclate	56	48
Potassium Chloride	Potassium Chloride	56	19
Metformin Hcl Er	Metformin Hcl	55	15
Hydralazine Hcl	Hydralazine Hcl	54	13
Oxybutynin Chloride Er	Oxybutynin Chloride	53	16
Nifedipine Er	Nifedipine	52	13
Ozempic	Semaglutide	51	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	14
Fenofibrate	Fenofibrate	48	13
Triamcinolone Acetonide	Triamcinolone Acetonide	48	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Glipizide Er	Glipizide	46	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	11
Ibandronate Sodium	Ibandronate Sodium	42	14
Warfarin Sodium	Warfarin Sodium	41	12
Buspirone Hcl	Buspirone Hcl	40	16
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Clonazepam	Clonazepam	39	suppressed
Diclofenac Sodium	Diclofenac Sodium	39	12
Farxiga	Dapagliflozin Propanediol	39	11
Januvia	Sitagliptin Phosphate	39	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	39	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	30
Pregabalin	Pregabalin	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	17
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Lorazepam	Lorazepam	32	suppressed
Ramipril	Ramipril	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Ondansetron Odt	Ondansetron	29	18
Memantine Hcl	Memantine Hcl	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Gemfibrozil	Gemfibrozil	26	suppressed
Ketoconazole	Ketoconazole	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	12
Xarelto	Rivaroxaban	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Cefuroxime	Cefuroxime Axetil	25	23
Celecoxib	Celecoxib	24	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	24	14
Fluconazole	Fluconazole	24	suppressed
Irbesartan	Irbesartan	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Baclofen	Baclofen	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Felodipine Er	Felodipine	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Levofloxacin	Levofloxacin	19	14
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Colchicine	Colchicine	18	suppressed
Linzess	Linaclotide	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Betamethasone Valerate	Betamethasone Valerate	17	suppressed
Glyburide	Glyburide	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Megestrol Acetate	Megestrol Acetate	16	suppressed
Mupirocin	Mupirocin	16	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Acyclovir	Acyclovir	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Azithromycin	Azithromycin	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Diazepam	Diazepam	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error